This report provides an analytical description of the use of medicines in 2024, in the national and regional context, through the processing of various information flows that make it possible to reconstruct pharmaceutical care in the community and in hospitals, both at the expense of the National Health Service (NHS) and through private purchases by citizens.

OsMed flows have been used for analysing consumption under the approved care regime, whereas the Medicine Traceability flows have been used to analyse the consumption of medicines purchased by health facilities.

In addition, for analysing prescriptions by age and sex and exposure and for estimating adherence and persistence, data from all Italian Regions, collected through the information flow of pharmaceutical prescriptions reimbursed by the NHS (Tessera Sanitaria/Health Card) have been analysed.

Data collected through the Medicine Traceability flow relating to medicines delivered to public and private pharmacies in the area was used to assess the cost to citizens.

Finally, the relevant regional flows were used to analyse the expenditure and consumption of medicines dispensed through direct and on‐behalf distribution.

Published on: 27 May 2026